TY - JOUR
T1 - TCF-1 controls Treg cell functions that regulate inflammation, CD8+ T cell cytotoxicity and severity of colon cancer
AU - Osman, Abu
AU - Yan, Bingyu
AU - Li, Ying
AU - Pavelko, Kevin D.
AU - Quandt, Jasmine
AU - Saadalla, Abdulrahman
AU - Singh, Mahendra Pal
AU - Kazemian, Majid
AU - Gounari, Fotini
AU - Khazaie, Khashayarsha
N1 - Funding Information:
This work was supported by NIH grants R01 AI 108682 (to F.G. and K.K.), RO1 AI 147652 (to F.G.) and R35GM138283 (to M.K.), and a Praespero Innovation Award Alberta, Canada (to F.G. and K.K.). N. Carapanceanu and V. Carapanceanu are thankfully acknowledged for excellent technical support. L. Pennell (BioLegend) is gratefully acknowledged for advice with scRNA-seq techniques. V. Simon (Mayo Clinic) is gratefully acknowledged for assistance with scRNA-seq. A. V. Lucs (Eli Lilly) is thankfully acknowledged for providing the TGF-βRI inhibitor LY3200882 and for scientific advice.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2021/9
Y1 - 2021/9
N2 - The transcription factor TCF-1 is essential for the development and function of regulatory T (Treg) cells; however, its function is poorly understood. Here, we show that TCF-1 primarily suppresses transcription of genes that are co-bound by Foxp3. Single-cell RNA-sequencing analysis identified effector memory T cells and central memory Treg cells with differential expression of Klf2 and memory and activation markers. TCF-1 deficiency did not change the core Treg cell transcriptional signature, but promoted alternative signaling pathways whereby Treg cells became activated and gained gut-homing properties and characteristics of the TH17 subset of helper T cells. TCF-1-deficient Treg cells strongly suppressed T cell proliferation and cytotoxicity, but were compromised in controlling CD4+ T cell polarization and inflammation. In mice with polyposis, Treg cell–specific TCF-1 deficiency promoted tumor growth. Consistently, tumor-infiltrating Treg cells of patients with colorectal cancer showed lower TCF-1 expression and increased TH17 expression signatures compared to adjacent normal tissue and circulating T cells. Thus, Treg cell–specific TCF-1 expression differentially regulates TH17-mediated inflammation and T cell cytotoxicity, and can determine colorectal cancer outcome.
AB - The transcription factor TCF-1 is essential for the development and function of regulatory T (Treg) cells; however, its function is poorly understood. Here, we show that TCF-1 primarily suppresses transcription of genes that are co-bound by Foxp3. Single-cell RNA-sequencing analysis identified effector memory T cells and central memory Treg cells with differential expression of Klf2 and memory and activation markers. TCF-1 deficiency did not change the core Treg cell transcriptional signature, but promoted alternative signaling pathways whereby Treg cells became activated and gained gut-homing properties and characteristics of the TH17 subset of helper T cells. TCF-1-deficient Treg cells strongly suppressed T cell proliferation and cytotoxicity, but were compromised in controlling CD4+ T cell polarization and inflammation. In mice with polyposis, Treg cell–specific TCF-1 deficiency promoted tumor growth. Consistently, tumor-infiltrating Treg cells of patients with colorectal cancer showed lower TCF-1 expression and increased TH17 expression signatures compared to adjacent normal tissue and circulating T cells. Thus, Treg cell–specific TCF-1 expression differentially regulates TH17-mediated inflammation and T cell cytotoxicity, and can determine colorectal cancer outcome.
UR - http://www.scopus.com/inward/record.url?scp=85112712683&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112712683&partnerID=8YFLogxK
U2 - 10.1038/s41590-021-00987-1
DO - 10.1038/s41590-021-00987-1
M3 - Article
C2 - 34385712
AN - SCOPUS:85112712683
SN - 1529-2908
VL - 22
SP - 1152
EP - 1162
JO - Nature immunology
JF - Nature immunology
IS - 9
ER -